These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1204832)

  • 41. [Animal experimental tests of the prothrombin synthesis inhibition effect of coumarin derivatives].
    Markwardt F; Haustein KO
    Acta Biol Med Ger; 1966; 17(3):318-26. PubMed ID: 5987646
    [No Abstract]   [Full Text] [Related]  

  • 42. Kinetics of anticoagulant effect of dicumarol in rats.
    Wingard LB; Levy G
    J Pharmacol Exp Ther; 1973 Jan; 184(1):253-60. PubMed ID: 4119618
    [No Abstract]   [Full Text] [Related]  

  • 43. Some effects of purified autoprothrombin C in blood clotting.
    Müller-Berghaus G; Seegers WH
    Thromb Diath Haemorrh; 1966 Dec; 16(3):707-22. PubMed ID: 5996683
    [No Abstract]   [Full Text] [Related]  

  • 44. Antagonism of the anti-thrombotic effect of warfarin by uric acid.
    Newland H
    Am J Med Sci; 1968 Jul; 256(1):44-52. PubMed ID: 5664331
    [No Abstract]   [Full Text] [Related]  

  • 45. New adjuvants to enhance anticoagulant activity of warfarin.
    Stromich JJ; Weber AK; Mirzaei YR; Caldwell MD; Lewis DE
    Bioorg Med Chem Lett; 2010 Mar; 20(6):1928-32. PubMed ID: 20167480
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanism of ticrynafen potentiation of coumarin anticoagulant action.
    Preusch PC; Suttie JW
    Biochem Pharmacol; 1983 Aug; 32(16):2393-8. PubMed ID: 6615542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coumarin drug interactions.
    Kazmier FJ; Spittell JA
    Mayo Clin Proc; 1970 Apr; 45(4):249-55. PubMed ID: 5439135
    [No Abstract]   [Full Text] [Related]  

  • 48. Hereditary resistance to coumarin anticoagulant drugs in man and rat.
    O'Reilly RA; Pool JG; Aggeler PM
    Ann N Y Acad Sci; 1968 Jul; 151(2):913-31. PubMed ID: 4189970
    [No Abstract]   [Full Text] [Related]  

  • 49. Sex differences in the anticoagulant effects of warfarin.
    Hara K; Akiyama Y; Tajima T
    Jpn J Pharmacol; 1994 Nov; 66(3):387-92. PubMed ID: 7869625
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Considerations on an international standard for the one-stage prothrombin time in the control of anticoagulant therapy.
    Loeliger EA; Hemker HC
    Thromb Diath Haemorrh Suppl; 1968; 35():101-5. PubMed ID: 4953165
    [No Abstract]   [Full Text] [Related]  

  • 51. Warfarin resistance induced by oxcarbamazepine.
    Nevruz O; Baysan O; Yokuşoğlu M
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):358-9. PubMed ID: 19666450
    [No Abstract]   [Full Text] [Related]  

  • 52. In vivo determination of the anticoagulant effect of a substituted isocoumarin (ACITIC).
    Oweida SW; Ku DN; Lumsden AB; Kam CM; Powers JC
    Thromb Res; 1990 Apr; 58(2):191-7. PubMed ID: 2349546
    [No Abstract]   [Full Text] [Related]  

  • 53. The anticoagulant activity of some selected warfarin analogues.
    Obaseki AO; Coker HB
    J Pharm Pharmacol; 1987 Feb; 39(2):142-4. PubMed ID: 2882003
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anticoagulant therapy standards: results of two national surveys.
    Poller L
    Thromb Diath Haemorrh Suppl; 1968; 35():115-2. PubMed ID: 5761059
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of sodium bicarbonate on the anticoagulant action of dicoumarol.
    SAPEIKA N; MERSKEY C
    Arch Int Pharmacodyn Ther; 1954 Oct; 99(3-4):391-4. PubMed ID: 13229446
    [No Abstract]   [Full Text] [Related]  

  • 56. [Research on a pyramidon derivative without delayed action on a simultaneously administered anticoagulant coumarin derivative].
    SCHULT A; GRUNDNER HG; HARTERT H
    Med Welt; 1962 Feb; 6():312-4. PubMed ID: 13909474
    [No Abstract]   [Full Text] [Related]  

  • 57. Synthesis and relative urinary excretion rates of the enantiomers of warfarin-4-14C and phenprocoumon-2-14C.
    Goding LA; West BD
    J Med Chem; 1969 May; 12(3):517-8. PubMed ID: 5788172
    [No Abstract]   [Full Text] [Related]  

  • 58. [Attempted demonstration of a circulating anticoagulant in subjects treated with 5-phenyl-propyl-4-hydroxycoumarin].
    Bourgain RH; Kahn MJ
    Arch Int Pharmacodyn Ther; 1969 Jun; 179(2):483-5. PubMed ID: 5367315
    [No Abstract]   [Full Text] [Related]  

  • 59. Eight-hourly prothrombin responses after induction dose of coumadin (Warfarin) sodium.
    BARKER H; RANGEL R
    Am J Cardiol; 1960 Nov; 6():933-6. PubMed ID: 13687010
    [No Abstract]   [Full Text] [Related]  

  • 60. [Studies on the effect of phenyl-indandione and of ethyl ester of dicoumarin on the blood with special reference to modifications of proconvertinemia and to utilization of prothrombin].
    BEAUMONT JL; GELE P
    Sang; 1953; 24(8):748-61. PubMed ID: 13135389
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.